.png)
Headquartered in France, Therapixel is an international company specialized in the design and commercialization of AI-based medical imaging software, with the goal of delivering pertinent information at the right time to healthcare professionals.
Winner of the Digital Mammography DREAM Challenge, the global competition on breast cancer detection with AI, Therapixel has developed MammoScreen®.
MammoScreen® is an AI-based proficiency tool that helps radiologists interpret mammograms more accurately and faster. Working alongside radiologists, its uniquely actionable MammoScreen Score™ allows radiologists — at a glance — to quickly confirm what they suspect while providing the accuracy to detect what may have been missed. This allows radiologists to concentrate their energies on the questionable cases that require further scrutiny.